<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73732">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01731743</url>
  </required_header>
  <id_info>
    <org_study_id>839 MP HEN 402-11</org_study_id>
    <nct_id>NCT01731743</nct_id>
  </id_info>
  <brief_title>Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carl Zeiss Meditec AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carl Zeiss Meditec AG</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <authority>Spain: Ethics Committee</authority>
    <authority>United Kingdom: National Institute for Health Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the far, intermediate and near visual acuities with
      a trifocal IOL.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best
      distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm)
      and near (40 cm) distance as well as the subjective refraction.

      A patient questionnaire will be used to assess the patient satisfaction and spectacle
      independence.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Intermediate visual acuity</measure>
    <time_frame>up to 3 months postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Monocular and binocular uncorrected and best distance corrected</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>near and far visual acuity</measure>
    <time_frame>1 and 3 month postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Monocular and binocular uncorrected and best distance corrected</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction and spectacle independence</measure>
    <time_frame>1 and 3 month postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>implantation of a trifocal IOL (AT LISA tri 839MP)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AT LISA tri 839MP</intervention_name>
    <arm_group_label>implantation of a trifocal IOL (AT LISA tri 839MP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman, over 50 years of age

          -  Bilateral implantation of a trifocal intraocular lens

          -  Capsular bag implantation

        Exclusion Criteria:

          -  Existing ocular pathology

          -  Surgical complications

          -  Corneal astigmatism ≥ 1.0D
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Carl Zeiss Meditec AG</name>
      <address>
        <city>Berlin</city>
        <zip>10589</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>November 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
